Zymogenetics' P2P Acquisition

Zymogenetics raised a round of funding on September 07, 2010. Investors include Bristol-Myers Squibb.

Zymogenetics focuses on developing a pipeline of therapeutic proteins indulging Recothrom for hemostasis.…

Articles about Zymogenetics' P2P Acquisition: